Xconomy

OCTOBER 11, 2016

Here’s a quick roundup of the major news. The first news of nivolumab’s Phase 3 failure in these first-line patients came in August and eliminated billions of dollars from Bristol’s market value. Clovis touted data from a “pooled” study of two mid-stage trials of rucaparib in ovarian cancer. LUNG CHECKS.

News 40

News Study Report Santa Monica 40

Startup Professionals Musings

MARCH 25, 2021

You can project the results by assessing how well you might handle these seven key objectives: Develop a simple plan for your complex strategy. I have found that many people are great critics, or can study a problem forever. Really listen for danger signals and bad news. Build teams that work together to drive strategy.

News 136

News Framework Demand Study 136

socalTECH

OCTOBER 29, 2012

And in particular, if you're developing comedy and humor content -- which is a big segment of the content being created--how to do you help people find the content which will resonate with them. We set up to develop that technology, in partnership with institutions and researchers, psychologists, and marketing professors.

Content 230

Content News Startup Research 230

socalTECH

MAY 8, 2017

What we are doing has the potential to allow companies to develop more, novel treatments, for conditions, more effectively. It's really hard to do the study which requires you to drive weekly to a clinic, find parking, deal with traffic, and wait in a waiting room. Belinda Tan: Most of our trials are Phase 2 and Phase 3 studies.

Technology 133

Technology Study UCLA Research 133

Startup Professionals Musings

JUNE 25, 2023

This intent is often negated, according to new studies, by remote workers , especially parents and team members with long commutes, who are more satisfied and productive than onsite employees. Communicate both good and bad news to provide transparency to team members. Make sure they understand the changes coming ahead.

Customer 113

Customer Custom Training Tool 113

Startup Professionals Musings

MARCH 5, 2021

Startups are the corporations of the future, so I have long believed that entrepreneurs who study existing corporate models, rather than ignoring them with disdain, will likely profit from the exercise. Luxury goods flood into emerging nations, and urbanization brings needs for sustainable development. Demographic shifts.

Marketing 135

Marketing Startup Entrepreneur Social Media 135

TechCrunch LA

MAY 25, 2019

For one, because millennials, according to various studies, are consuming less alcohol than previous generations and are therefore seeking non-alcoholic beverage alternatives. On to other news. Takeaways from KubeCon; the latest on Kubernetes and cloud-native development . Founders say yes. IPO Corner.

Startup 223

Startup Venture Capital Newsletter Tips 223

Xconomy

JUNE 27, 2016

Regulus reported that a second serious case of jaundice, or a yellowing of the skin and eyes, in a Phase 1 study of RG-101. Regulus said the hold won’t impact timelines for its three ongoing studies of RG-101, because it has already treated the patients in those trials—two Phase 2 studies and a single Phase 1 study.

Study 52

Study News Report Conference 52

Tech Zulu Event

DECEMBER 21, 2011

IconFinder provides high quality icons for webdesigners and developers in an easy and efficient way. Before Iconfinder I was working as a web designer and front-end developer, next to studying computer science and business administration. Steffen was working in another startup called 1Calendar and studying as well.

Design 65

Design Web Design Google Develop 65

Xconomy

DECEMBER 20, 2016

An Acadia Pharmaceuticals drug developed to treat hallucinations and delusions experienced by Parkinson’s disease patients is now showing signs it could also treat similar psychoses associated with Alzheimer’s disease. Investors cheered the news, boosting Acadia’s stock price 13.6 percent to $28.88 in trading Tuesday morning.

San Diego 40

San Diego Statistics Study News 40

Xconomy

NOVEMBER 7, 2016

Up until this point, studies of an experimental drug from Biogen and Ionis Pharmaceuticals had focused on patients with the most severe form of a rare, potentially deadly genetic disorder called spinal muscular atrophy. But new data released this morning show that the therapy, known as nusinersen (Spinraza), could have a much broader reach.

Help 97

Help Study Research Statistics 97

Startup Professionals Musings

MARCH 21, 2022

That’s good news for all business segments and the economy. The building of new houses, communities, and infrastructure – as well as the new demand for retail that delivers – will strain trucking and shipping to its limits. With 330 million people in the U.S. Shipping and delivery: Strained to the limits.

Demand 103

Demand Startup Course Summary 103

socalTECH

JULY 20, 2011

Earlier this month, Los Angeles-based HitFix (www.hitfix.com) an online news site focused on entertainment, announced it had raised $2M in a funding round. We spoke with Jennifer about what HitFix is looking to do, her own background, and how HitFix is different from the many celebrity gossip and news sites out there.

News 173

News Entertainment Startup Bertelsmann 173

Xconomy

DECEMBER 5, 2018

Let’s get caught up with the latest life sciences news in San Diego. The San Diego biotech is developing therapies for cancers related to the Epstein-Barr virus. Even as all eyes were on the American Society of Hematology (ASH) conference in downtown San Diego this week, other biotech companies were staying busy.

San Diego 79

San Diego Conference News Develop 79

Xconomy

OCTOBER 7, 2016

—Alnylam Pharmaceuticals (NASDAQ: ALNY ) of Cambridge, MA, said that it would shelve its drug revusiran after 18 patients died in a Phase 3 study to treat the rare disease transthyretin amyloidosis. CLINICAL NEWS. She refused to discuss Edison at the time. Shares immediately fell more than 40 percent. —The U.S.

Technical Review 77

Technical Review Study Layoffs San Diego 77

socalTECH

AUGUST 2, 2013

Yapert raised a funding round a few weeks ago from the Tech Coast Angels, Desert Angeles, and Pasadena Angels for its mobile apps, which consolidates news and information about your favorite interests. We really started to study the current generation of smartphones and what people do with them. How did the company start?

Mobile 159

Mobile Startup Entertainment Tech Coast Angels 159

Xconomy

AUGUST 8, 2016

After reporting encouraging news last week from a mid-stage trial of its lead anti-cancer drug, San Diego’s MEI Pharma (NASDAQ: MEIP ) said it has signed a drug development deal with the Swiss pharmaceutical group Helsinn that could eventually be worth over $464 million. Reprints | Share:

Study 40

Study San Diego News Design 40

Tech Zulu Event

JUNE 5, 2015

A new third-party study commissioned by Disney reveals that parents feel nostalgia for the way they used to play growing up and that they also have a desire to keep their kids active. The study also found that children enjoy being active—yet at the same time, they have a growing appetite for technology-infused products.

Study 40

Study Activity News Entertainment 40

Xconomy

JULY 18, 2016

in New York. The company is developing a nasal formulation of metoclopramide, , an already-approved treatment for digestive pain and other symptoms related to the stomach being unable to empty its contents. Others have had trouble developing a treatment for diabetic gastroparesis, too. per share as of 11:30 a.m.

Study 40

Study Sites News Research 40

socalTECH

DECEMBER 30, 2016

What's the biggest news from you or your‏ firm this year? I studied East Asian religions in college and was intrigued to hear that a Buddhist monk was delivering meditation and mindfulness via a mobile app. Here, we have the thoughts of Rob Freelen of Silicon Valley Bank (www.svb.com).

Santa Monica 124

Santa Monica Southern California Venture Capital SoCalTech 124

Xconomy

APRIL 20, 2018

The biggest news this week was in oncology, hands down. While pembrolizumab notched the headline-grabbing data, others are also working to develop options for various subsets of patients.

Pricing 52

Pricing News Report Develop 52

Xconomy

JULY 8, 2016

But the news in our little corner of the world doesn’t stop. —Another health scourge was in the news: hepatitis. British medical journal The Lancet published a study , funded by the Bill and Melinda Gates Foundation, that showed viral hepatitis has become the seventh leading cause of death globally, up from tenth in 1990.

Pricing 52

Pricing News Journal Startup 52

Xconomy

SEPTEMBER 9, 2016

The scientific goals, writ large, included nationwide data sharing among researchers and drug developers; better prevention through medicine (such as the HPV vaccine) and public education (anti-smoking campaigns); and a registry that could match cancer patients to trials based on genetics and other factors.

Pricing 40

Pricing Startup News Screening 40

Xconomy

JULY 29, 2016

Amongst several companies to report this week, the biggest news came from Gilead Sciences (NASDAQ: GILD ), whose hepatitis C drugs have become some of the top revenue producers in the industry. The study is one of several Celgene is running to try to expand the use of its blockbuster blood cancer drug. Shares fell more than 75 percent.

Startup 40

Startup Study News Report 40

Startup Professionals Musings

JULY 8, 2015

According to a classic Gompers and Lerner study, the challenge is very real, with a majority of new ventures that don't attract investors failing within the first three years. Leave the world of new computer chips and new drugs to the big companies, and people with deep pockets. Apply for contests and business grants.

Entrepreneur 105

Entrepreneur Startup Technical Review Equity 105

socalTECH

DECEMBER 5, 2012

I always said--how much better would life be if I could sit at a table of locals, eat, and talk about our commonalities, and get local insider news. The thing about SupperKing, is you get to meet new people and interact with them, build new friendships, and it's not just about monetization. What were you doing before?

Platform 250

Platform Mobile UCLA Sites 250

Startup Professionals Musings

JULY 14, 2014

According to a Gompers and Lerner study, the challenge is very real, with a majority of new ventures that don''t attract investors failing within the first three years. My first advice for new entrepreneurs is to pick a domain that doesn’t have the sky-high up-front development costs, like online web sites and smart phone apps.

Entrepreneur 113

Entrepreneur Funding Startup Technical Review 113

socalTECH

DECEMBER 5, 2012

I always said--how much better would life be if I could sit at a table of locals, eat, and talk about our commonalities, and get local insider news. The thing about SupperKing, is you get to meet new people and interact with them, build new friendships, and it's not just about monetization. What were you doing before?

Platform 247

Platform Mobile UCLA Sites 247

Startup Professionals Musings

JUNE 16, 2019

That’s good news for all business segments and the economy. The building of new houses, communities, and infrastructure – as well as the new demand for retail that delivers – will strain trucking and shipping to its limits. With 330 million people in the U.S. Shipping and delivery: Strained to the limits.

Demand 83

Demand Startup Course Summary 83

Xconomy

NOVEMBER 11, 2016

Here’s what we know: There’s news to round up. CRISPR DEVELOPMENTS. The Nitto drug is in a Phase 1b study. —The FDA lifted a partial clinical hold , meanwhile, on a planned cell therapy study from Philadelphia and U.K.-based Let’s get to it. TOP STORIES. 6 at the U.S.

Patents 87

Patents Study Pricing Research 87

Xconomy

NOVEMBER 17, 2017

In our roundup this week, Alzheimer’s disease is in the news, thanks to billionaire Bill Gates and his personal pledge of $100 million toward R&D. That could equal the amount one startup hopes to raise in an IPO to develop drugs for Alzheimer’s and other brain diseases.

News 45

News Report Startup Develop 45

Xconomy

OCTOBER 28, 2016

In the meantime, however, the news hasn’t been all bad for drugmakers. And new treatments to expand the reach of cystic fibrosis therapies have begun clinical testing. The news came with some caveats, however, as TheStreet.com explains here. AND IN OTHER NEWS…. difficile infection. .

Pricing 40

Pricing Conference News Study 40

Xconomy

AUGUST 2, 2016

Officials at USA Football had to concede that they did not review the data from the study carefully and did not realize that the positive data they were publicizing contradicted data from the same study published one year ago that showed negative results for the Heads Up Football program.

Study 40

Study Training News Statistics 40

Both Sides of the Table

SEPTEMBER 21, 2016

The news blogs will cover the what, how and how much but I want to focus on the “why” and try to be instructive of what I think makes for a great A-round startup. 70% Team, 30% Market I also talk often about how much the team plays a critical role in my decision backing an A-round company because so much changes as a company develops.

Design 150

Design Ideas Startup Writing 150

Xconomy

SEPTEMBER 30, 2016

Who will be first to market with a new type of cancer treatment known as CAR-T? Who will break free of the pack of companies developing drugs meant to prevent migraines? —A leadership void was created for New York biotech when Marc Tessier-Lavigne left Rockefeller University to run Stanford. TheStreet.com has more here.

Avalon 40

Avalon Thousand Oaks Study Startup 40

Startup Professionals Musings

FEBRUARY 19, 2013

According to a Gompers and Lerner study, the challenge is very real, with 90% of new ventures that don't attract investors failing within the first three years. My first advice for new entrepreneurs is to pick a domain that doesn’t have the sky-high up-front development costs, like online web sites and smart phone apps.

Startup 123

Startup Technical Review Equity Incubator 123

Both Sides of the Table

FEBRUARY 27, 2010

There have been many studies done on the topic including looking at twins raised in separate families. There have been studies of adopted children to their natural parents versus the parents that raised them. I have also seen studies on “birth order.&#. You’re not born into being a world-class software developer.

Startup 289

Startup Statistics Entrepreneur Study 289